Garden State to receive cut from Trump admin's $1.8B to combat opioid crisis.

Byline: Anthony Vecchione

The U.S. Department of Health and Human Services on Wednesday announced roughly $1.8 billion in funding from the Trump administration to state and local governments to tackle the opioid crisis.

The money will come from the Centers for Disease Control and Substance Abuse and Mental Health Services (SAMHS). CDC will spend $900 million over three years to track overdose data and SAMHS is awarding $932 million, disbursed among all 50 states, to help support prevention, treatment and recovery services.

The funding will support "expanding the use of medication-assisted treatment in criminal justice settings or in rural areas via telemedicine to youth-focused, community-based prevention efforts, recovery supports like employment coaching, and support for the distribution of naloxone," as well as tracking opioid overdoses, according to the HHS.

This funding from CDC will help state and local governments track overdose data as closely to real-time as possible and support them in work to prevent overdoses and save lives. Funding for the first year is being awarded to 47 states, Washington, D.C., 16 localities, and two territories.

The New Jersey Department of Health is being allocated a $7,433,765 grant from the CDC.

The State Opioid Response (SOR) grants from the Substance Abuse and Mental Health Services Administration provide flexible funding to state governments to support prevention, treatment, and recovery services in the ways that meet the needs of their state.These grants have been awarded to all 50 states, Washington, D.C., and U.S. territories.

In addition to the approximately $500 million released earlier this year, SAMHSA released $932 million in continuation funding to support the second year of the State...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT